Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Edwards

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Haematologica|October 5, 2023
Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 inductionLuca Gasparoli, Clemence Virely, Alexia Tsakaneli, et al.
Pediatric Blood & Cancer|December 31, 2021
High-throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B-cell acute lymphoblastic leukemia: A prospective feasibility studyJack Bartram, Gary Wright, Stuart Adams, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonistsPhillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
British Journal of Haematology|March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cellsHugues deLavallade, William Wilson, Rachel Protheroe, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2011
Identification of potent, soluble, and orally active TRPV1 antagonistsPaul Ratcliffe, John Maclean, Lynn Abernethy, et al.
Drug Testing and Analysis|November 23, 2021
The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisonsRobert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
ACS Omega|January 8, 2026
Compounds Reducing Human Sperm Motility as Potential Nonhormonal Contraceptives Identified Using a High-Throughput Phenotypic Screening PlatformAnthony Richardson, Franz S Gruber, David P Day, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Haematologica|October 5, 2023
Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 inductionLuca Gasparoli, Clemence Virely, Alexia Tsakaneli, et al.
Pediatric Blood & Cancer|December 31, 2021
High-throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B-cell acute lymphoblastic leukemia: A prospective feasibility studyJack Bartram, Gary Wright, Stuart Adams, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonistsPhillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
British Journal of Haematology|March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cellsHugues deLavallade, William Wilson, Rachel Protheroe, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2011
Identification of potent, soluble, and orally active TRPV1 antagonistsPaul Ratcliffe, John Maclean, Lynn Abernethy, et al.
Drug Testing and Analysis|November 23, 2021
The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisonsRobert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
ACS Omega|January 8, 2026
Compounds Reducing Human Sperm Motility as Potential Nonhormonal Contraceptives Identified Using a High-Throughput Phenotypic Screening PlatformAnthony Richardson, Franz S Gruber, David P Day, et al.
Pageof 3